Naprapathy :: Scientific breakthrough for naprapathy
Naprapathy works better on back and neck trouble than recommended and proven effective advice from doctors, according to a new study from Swedish medical university Karolinska Institutet.
Naprapathy works better on back and neck trouble than recommended and proven effective advice from doctors, according to a new study from Swedish medical university Karolinska Institutet.
GlaxoSmithKline announced an important milestone for advanced breast cancer patients across Europe with approval of the first oral ErbB1 and ErbB2 dual inhibitor, Tyverb? (lapatinib).
A James P. Wilmot Cancer Center scientist recently received two research grants, totaling more than $1.5 million, for separate, divergent studies of new therapies for follicular and mantle cell lymphomas.
When Sociologist Rene Almeling decided to look into the operations of U.S. sperm banks and egg agencies, the UCLA Ph.D. candidate in sociology thought she knew what she would find.
A guideline developed by the American Academy of Neurology finds conventionally recommended courses of antibiotics are highly effective for treating nervous system Lyme disease.
Aspirin therapy?s ability to reduce the risk of colorectal cancer, an association seen in a large number of studies, appears to depend on the drug?s inhibition of the COX-2 enzyme, the action that also underlies aspirin?s usefulness for treating pain and inflammation.
Researchers from the University of Pennsylvania School of Medicine found in a database study of women heart patients that COX inhibitors such as traditional nonsteroidal anti-inflammatory drugs (NSAIDs) may undermine any purported protection against heart disease in participants taking estrogen therapy. The results were described this week in PLoS Medicine.
Despite improvements in the ability to diagnose malaria, these diagnostic tests are often underused in Zambia, and patients with negative test results are often prescribed anti-malaria medications, according to a study in the May 23/30 issue of JAMA, a theme issue on malaria.
Ugandan children who received the combination therapy of artemether-lumefantrine experienced a lower rate of treatment failure compared to other combination therapies, according to a study in the May 23/30 issue of JAMA, a theme issue on malaria.
Each year, the parents of an estimated one in 20,000 newborns are shocked to learn their child has type 1 congenital myotonic dystrophy (CDM1), a progressive and crippling genetic disorder.